Modotuximab Uses, Dosage, Side Effects and more
Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).
| Trade Name | Modotuximab |
| Generic | Modotuximab |
| Modotuximab Other Names | Modotuximab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
